Back to search

National and Kapodistrian University of Athens

Επίδραση αντιαγγειογενετικών παραγόντων στη νεοαγγείωση του κερατοειδούς

Abstract

dc:description

Purpose: 1.To evaluate the effect of subconjunctival injection of Bevacizumab on experimentally induced corneal neovascularization.2.To evaluate the effect of the subconjunctival administration of the anti-vascular endothelial growth factor (VEGF) Ranibizumab on corneal neovascularization and on ocular tissues.Material and Methods: 1.Experimental animal study.Twelve N.Zealand white rabbits were involved, divided equally into 4 groups. Only one eye per rabbit was used. Topical instillation of 10μl of 5% NaOH solution was used, under general anesthesia, to induce corneal neovascularization secondary to corneal alkali burn in groups 2,3 and 4. A single dose of 3.75mg (25mg/ml) Bevacizumab was injected subconjunctivally. Group 1 (control group 1) was neither cauterized nor treated. Group 2 (control group 2) received a sham injection of BSS on day 14. Group 3 was treated on day 14 (after corneal neovascularization had been established). Group 4 was treated on day 1. Digital photographs were taken and analysed during the whole 28-day procedure. The area of neovascularization and scarring were measured in terms of the percentage of corneal surface affected.2.In phase “B” of this experimental study and laboratory investigation, chemical cauterization was utilized to induce corneal neovascularization in 16 rabbits randomly divided in 2 equal groups. Cauterized eyes were either treated with 0.1ml (1mg) of subconjunctival ranibizumab or administered a sham injection. A third group of 4 rabbits served as control for side-effects after ranibizumab administration. All animals were monitored daily for 14 days and the extent of corneal scarring and neovascularization was measured on days 1, 7 and 14. After enucleation, ocular tissues were separated under a surgical microscope and VEGF levels were measured with ELISA. Statistical analysis was performed to compare the extent of corneal neovascularization and VEGF levels between treated and untreated eyes. Results: 1.On day 28, the difference of neovascularization between Groups 2-3-4 was found to be statistically significant at the 0.05 level (one-way ANOVA): Group 4 (4.7±3.1%) < Group 3 (13.3±2.3%) < Group 2 (41.0±3.6%), (p<0.05, Mann-Whitney U test). In Group 3, neovascularization area decreased by 42%, 14 days post treatment. Neovascularization was almost completely absent in group 4. The development of scarring was unaffected by Bevacizumab (p>0.1, one-way ANOVA). No side-effects were noticed. 2.Subconjunctival ranibizumab inhibited corneal neovascularization both in the first and the second week compared to untreated controls (P=0.01 and P<0.001 respectively). VEGF levels were significantly lower in the cornea, iris, aqueous humor and conjunctiva of the treated eyes (P<0.01). The reduction of VEGF levels ranged from 20-70% in different ocular tissues. Corneal scarring was not significantly affected by anti-VEGF treatment (P=0.645). No side-effects were noticed.Conclusions: Subconjunctival administration of Bevacizumab inhibits corneal neovascularization effectively, in the rabbit experimental model, especially if administered within the first 2 weeks after corneal trauma. Early subconjunctival administration of Ranibizumab may successfully inhibit alkali induced corneal neovascularization in an animal model. Subconjunctival Ranibizumab reduces VEGF levels significantly not only in the cornea and the bulbar conjunctiva but also in the aqueous humor and the iris.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2013

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Liarakos, Vasilios
  • Λιαράκος, Βασίλειος

Subjects

dc:subject × 35

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/40212

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Liarakos, Vasilios; Λιαράκος, Βασίλειος. Επίδραση αντιαγγειογενετικών παραγόντων στη νεοαγγείωση του κερατοειδούς. National and Kapodistrian University of Athens, 2013. http://hdl.handle.net/10442/hedi/40212